1113 related articles for article (PubMed ID: 32032202)
21. Anal Adenocarcinoma Treated in the Era of Total Neoadjuvant Therapy and Nonoperative Management.
Feferman Y; Rosen RY; Gebran S; Yuval JB; Kerioui M; Gönen M; Wei IH; Widmar M; Nash GM; Weiser MR; Paty PB; Hajj C; Roth O'Brien DA; Romesser PB; Crane CH; Smith JJ; Garcia Aguilar J; Pappou EP
Dis Colon Rectum; 2024 Apr; 67(4):496-504. PubMed ID: 38127627
[TBL] [Abstract][Full Text] [Related]
22. Local Recurrence-Free Survival After TaTME: A Canadian Institutional Experience.
Hershorn O; Ghuman A; Karimuddin AA; Raval MJ; Phang PT; Brown CJ
Dis Colon Rectum; 2024 May; 67(5):664-673. PubMed ID: 38319633
[TBL] [Abstract][Full Text] [Related]
23. Salvage Surgery With Organ Preservation for Patients With Local Regrowth After Watch and Wait: Is It Still Possible?
Fernandez LM; Figueiredo NL; Habr-Gama A; São Julião GP; Vieira P; Vailati BB; Nasir I; Parés O; Santiago I; Castillo-Martin M; Carvalho C; Parvaiz A; Perez RO
Dis Colon Rectum; 2020 Aug; 63(8):1053-1062. PubMed ID: 32692070
[TBL] [Abstract][Full Text] [Related]
24. Total Neoadjuvant Therapy With Short-Course Radiation: US Experience of a Neoadjuvant Rectal Cancer Therapy.
Chapman WC; Kim H; Bauer P; Makhdoom BA; Trikalinos NA; Pedersen KS; Glasgow SC; Mutch MG; Silviera ML; Roy A; Parikh PJ; Hunt SR
Dis Colon Rectum; 2022 Feb; 65(2):198-206. PubMed ID: 34990423
[TBL] [Abstract][Full Text] [Related]
25. Does Completeness of the Mesorectal Excision Still Correlate With Local Recurrence?
Garoufalia Z; Freund MR; Gefen R; Meyer R; DaSilva G; Weiss EG; Wexner SD
Dis Colon Rectum; 2023 Jul; 66(7):898-904. PubMed ID: 36649177
[TBL] [Abstract][Full Text] [Related]
26. Tailored Strategy for Locally Advanced Rectal Carcinoma (GRECCAR 4): Long-term Results From a Multicenter, Randomized, Open-Label, Phase II Trial.
Rouanet P; Rullier E; Lelong B; Maingon P; Tuech JJ; Pezet D; Castan F; Nougaret S;
Dis Colon Rectum; 2022 Aug; 65(8):986-995. PubMed ID: 34759247
[TBL] [Abstract][Full Text] [Related]
27. Self-Expanding Metal Stents Do Not Adversely Affect Long-term Outcomes in Acute Malignant Large-Bowel Obstruction: A Retrospective Analysis.
Browne IL; Mahsin M; Drolet S; Buie WD; Heine JA; MacLean AR
Dis Colon Rectum; 2022 Feb; 65(2):228-237. PubMed ID: 34990424
[TBL] [Abstract][Full Text] [Related]
28. Local Regrowth and the Risk of Distant Metastases Among Patients Undergoing Watch-and-Wait for Rectal Cancer: What Is the Best Control Group? Multicenter Retrospective Study.
São Julião GP; Fernández LM; Vailati BB; Habr-Gama A; Azevedo JM; Santiago IA; Parés O; Parvaiz A; Vendrely V; Rullier A; Rullier E; Denost Q; Perez RO
Dis Colon Rectum; 2024 Jan; 67(1):73-81. PubMed ID: 37493198
[TBL] [Abstract][Full Text] [Related]
29. Lateral Pelvic Nodal Management and Patterns of Failure in Patients Receiving Short-Course Radiation for Locally Advanced Rectal Cancer.
Hassanzadeh C; Mirza K; Kalaghchi B; Fallahian F; Chin RI; Roy A; Stowe H; Low G; Pedersen K; Wise P; Glasgow S; Roach M; Henke L; Badiyan S; Mutch M; Kim H
Dis Colon Rectum; 2024 Jan; 67(1):54-61. PubMed ID: 37787502
[TBL] [Abstract][Full Text] [Related]
30. Perirenal Fat Surface Area and Oncologic Outcome in Elective Colon Cancer Surgery.
Eckberg SE; Dahlberg MJA; der Hagopian OS; Farahnak P; Sandblom GK; Nordenvall CAM; Everhov ÅH
Dis Colon Rectum; 2021 Feb; 64(2):171-180. PubMed ID: 33315716
[TBL] [Abstract][Full Text] [Related]
31. Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in ypT0-1 Rectal Cancer After Preoperative Radiochemotherapy: Postoperative Morbidity, Functional Results, and Long-term Oncologic Outcome.
Rizzo G; Pafundi DP; Sionne F; Pietricola G; D'Agostino L; Gambacorta MA; Valentini V; Coco C
Dis Colon Rectum; 2022 Nov; 65(11):1306-1315. PubMed ID: 35067503
[TBL] [Abstract][Full Text] [Related]
32. Robot Surgery Shows Similar Long-term Oncologic Outcomes as Laparoscopic Surgery for Mid/Lower Rectal Cancer but Is Beneficial to ypT3/4 After Preoperative Chemoradiation.
Park SY; Lee SM; Park JS; Kim HJ; Choi GS
Dis Colon Rectum; 2021 Jul; 64(7):812-821. PubMed ID: 33833141
[TBL] [Abstract][Full Text] [Related]
33. A Prospective Multicenter Phase II Study on the Feasibility and Efficacy of S-1 and Oxaliplatin Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer.
Sakamoto Y; Morohashi H; Miura T; Tsutsumi S; Takahashi S; Hirama K; Wakiya T; Hakamada K
Dis Colon Rectum; 2022 May; 65(5):663-671. PubMed ID: 33833145
[TBL] [Abstract][Full Text] [Related]
34. Oncological Outcomes of Transanal Endoscopic Surgery for the Surgical Management of T2 and T3 Rectal Cancer.
Johnson GGRJ; Robertson RL; Vergis A; Raval M; Phang T; Karimuddin A; Brown C
Dis Colon Rectum; 2023 Jul; 66(7):1012-1021. PubMed ID: 36876985
[TBL] [Abstract][Full Text] [Related]
35. Patient Survival With ypT0N+ Following Neoadjuvant Therapy in Rectal Cancer.
Elshami M; Goldstone RN; Blaszkowsky LS; Cusack JC; Hong TS; Wo JY; Qadan M
Dis Colon Rectum; 2022 Oct; 65(10):1224-1231. PubMed ID: 35714358
[TBL] [Abstract][Full Text] [Related]
36. Nonoperative Management Versus Radical Surgery of Rectal Cancer After Neoadjuvant Therapy-Induced Clinical Complete Response: A Markov Decision Analysis.
de Buck van Overstraeten A; Khorasani S; Kennedy E; Look Hong NJ
Dis Colon Rectum; 2020 Aug; 63(8):1080-1089. PubMed ID: 32398412
[TBL] [Abstract][Full Text] [Related]
37. Case-Matched Comparison of Functional and Quality of Life Outcomes of Local Excision and Total Mesorectal Excision Following Chemoradiotherapy for Rectal Cancer.
Brachet S; Meillat H; Chanez B; Ratone JP; Brunelle S; Tyran M; Poizat F; de Chaisemartin C; Lelong B
Dis Colon Rectum; 2022 Dec; 65(12):1464-1474. PubMed ID: 35913830
[TBL] [Abstract][Full Text] [Related]
38. Prediction of Poor Response to Neoadjuvant Chemoradiation in Patients With Rectal Cancer Using a DNA Repair Deregulation Score: Picking the Losers Instead of the Winners.
Jimenez L; Perez RO; São Julião GP; Vailati BB; Fernandez LM; Gama-Rodrigues J; Habr-Gama A; DeVecchio J; Kalady MF; Camargo AA
Dis Colon Rectum; 2020 Mar; 63(3):300-309. PubMed ID: 31842156
[TBL] [Abstract][Full Text] [Related]
39. Limits of Clinical Restaging in Detecting Responders After Neoadjuvant Therapies for Rectal Cancer.
Deidda S; Spolverato G; Capelli G; Bao RQ; Bettoni L; Crimì F; Zorcolo L; Pucciarelli S; Restivo A
Dis Colon Rectum; 2023 Jul; 66(7):957-964. PubMed ID: 36538694
[TBL] [Abstract][Full Text] [Related]
40. Locally Excised T1 Rectal Cancers: Need for Specialized Surveillance Protocols.
Kwakye G; Curran T; Uegami S; Finne CO; Lowry AC; Madoff RD; Jensen CC
Dis Colon Rectum; 2019 Sep; 62(9):1055-1062. PubMed ID: 31318766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
